Stable high concentration sodium chloride formulations containing pd-1 antibody and methods of use thereof
AssigneeBeiGene Switzerland GmbH
InventorsJun WU, Xiaoqing JIN, Yu JI, Sufang GU, Jian SHEN, Bo QIU
Life of this patent
Estimating the term…
Loading patent…
AssigneeBeiGene Switzerland GmbH
InventorsJun WU, Xiaoqing JIN, Yu JI, Sufang GU, Jian SHEN, Bo QIU
Estimating the term…
The present invention relates generally to the field of pharmaceutical formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof. The formulations may further contain a histidine buffer, an inorganic salt, a sugar polyol, and a non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit low viscosity and a substantial degree of antibody stability after being subjected to thermal and other physical stress. Also provided are methods of making and methods of using such antibody formulations.
A low viscosity pharmaceutical formulation comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of making an antibody formulation, the method comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.